https://www.selleckchem.com/TGF-beta.html
The business of clinical research has changed in the past two decades, shifting from industrialised Western countries to so-called emerging markets such as Eastern Europe, Latin America and Africa. An appraisal of the trends could identify associated factors that may have implications for the local populations and their endemic diseases. To identify potential reasons why emerging countries have become attractive places for international sponsors to conduct their clinical trials. Using ClinicalTrials.gov, the Pan African Clinical Trials Registry
Like
Comment
Share
